background: we aimed to value the usefulness of free to total prostate-specific antigen and prostate-specific antigen (psa) density for prostate cancer in the patients with psa levels of 4.0 ng/ml or less. methods: a total of 343 subjects with psa levels of 4.0 ng/ml or less were biopsied. all patients were divided into four groups according to the psa levels: 0 to 1.0 ng/ml, 1.1 to 2.0 ng/ml, ...

psa is a 33-kda serine protease that is produced predominantly by prostate epithelium. however, it has been shown that about 30-40% of female breast tumors produce psa and its production is associated with the presence of estrogen and progesterone receptors. we have now developed a new tissue culture system to study psa production in breast cancer and its association with prognostic factors suc...

background and objective: prostate cancer is a prevalent disease around the world. the prostatic specific antigen (psa) test has recently proved itself as a useful method for the diagnosis and examination of patients with prostatic cancer. the objective of this study was to compare the stability of free psa and total psa in different storage settings. materials and methods: samples were obtaine...

background defining the optimal prostate-specific antigen threshold to identify the patients at the highest risk of prostate cancer has always been a controversial issue. objectives this study aims to analyze the diagnostic value of psa and also evaluate the relationship between psa (prostate-specific antigen) and bmi (body mass index) as well as psa and prostate size and volume in asymptomatic...

background: the normal prostate-specific antigen (psa) level in patients with urethral catheterization is a controversy. we designed this study to investigate the effect of nontraumatic urethral catheterization without urinary retention on serum psa. materials and methods: seventy patients scheduled for urethral catheterization before elective surgeries were randomly selected and included in th...

background: breast cancer is the most common cancer in women. prostate‑specifc antigen  (psa) is a marker of prostate gland malignancy, which has been considered in cases with breast cancer in recent years. the goal of this study was to determine total and free psa levels in cases with malignant and benign breast lesions. methods:   in  this case–control study, ninety women with histological pr...